CD47 in the Brain and Neurodegeneration: An Update on the Role in Neuroinflammatory Pathways
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
CD47 is a receptor belonging to the immunoglobulin (Ig) superfamily and broadly expressed on cell membranes. Through interactions with ligands such as SIRPα, TSP-1, integrins, and SH2-domain bearing protein tyrosine phosphatase substrate-1 (SHPS-1), CD47 regulates numerous functions like cell adhesion, proliferation, apoptosis, migration, homeostasis, and the immune system. In this aspect, previous research has shown that CD47 modulates phagocytosis via macrophages, the transmigration of neutrophils, and the activation of T-cells, dendritic cells, and B-cells. Moreover, several studies have reported the increased expression of the CD47 receptor in a variety of diseases, including acute lymphoblastic leukemia (ALL), chronic myeloid leukemia, non-Hodgkin’s lymphoma (NHL), multiple myeloma (MM), bladder cancer, acute myeloid leukemia (AML), Gaucher disease, Multiple Sclerosis and stroke among others. The ubiquitous expression of the CD47 cell receptor on most resident cells of the CNS has previously been established through different methodologies. However, there is little information concerning its precise functions in the development of different neurodegenerative pathologies in the CNS. Consequently, further research pertaining to the specific functions and roles of CD47 and SIRP is required prior to its exploitation as a druggable approach for the targeting of various neurodegenerative diseases that affect the human population. The present review attempts to summarize the role of both CD47 and SIRP and their therapeutic potential in neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 NIREGs such as CD47 provide “don’t eat me signals” and keep microglia in a homeostatic state. Adapted from [14].](https://figures.cochat.ai/paper-figures/96048cfd699f4113b9fa66e97de8ef82/cd47-in-the-brain-and-neurodegeneration-an-update-on-the-role-in-figure-1.jpg)
![Figure 2 The cell-to-cell cross-talk via the SIRPα-CD47 signaling. (A) Bi-directional signaling between CD47 and SIRPα. CD47 and SIRPα are possibly co-expressed on a similar cell and their ligation could mediate the inter-cellular signaling in a bi-directional manner. Even though SIRPα-CD47 signaling in the microglia is incompletely understood, the specific contribution of SIRPα and CD47 has been examined. Moreover, CD47 and SIRPα interactions could be observed in the phagocytic function of the microglia. (B) SIRP signaling in microglia. SIRPα phosphorylation enables the docking and the recruitment of SHP-1 and SHP-2. In this regard, various studies have shown that SHP-1 and SHP-2 perform opposite biological functions. Different signaling pathways have been negatively regulated by SHP-1 for the inhibition of numerous cell functions like phagocytosis. On the contrary, events affecting the cellular activity such as migration, as well as growth, have been shown to be positively regulated by SHP-2 [5]. Abbreviation: GPCR: G protein-coupled receptor, SIRPα: Signal regulatory protein α, SHP 1/2: SH2 domain-containing phosphatases 1 and 2, SHIP: SH2 domain-containing inositol phosphatase.](https://figures.cochat.ai/paper-figures/7de286881969484abc86062f9d4272fc/cd47-in-the-brain-and-neurodegeneration-an-update-on-the-role-in-figure-2.jpg)
![Figure 3 Improvement of functional recovery from contusive thoracic SCI by CD47 inhibition. CD47 suppression increases the vascular patency following the SCI. Moreover, CD47 suppression reduces neutrophil extravasation into the contusion. For this reason, CD47 has been considered a new treatment target to treat SCI. Adapted from [7].](https://figures.cochat.ai/paper-figures/2d2f52d6c65e4bc48f1697fe3794f94a/cd47-in-the-brain-and-neurodegeneration-an-update-on-the-role-in-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Similarly, blood testing has identified genes (e.g., NRG1 which is involved in regulation of proliferation, survival, and differentiation of many cell types including neurons and epithelial cells207), proteins (e.g. CD47 which is implicated in neuroinflammatory cascades208), and proinflammatory markers (IL-1β, IL-6)209-211 that are associated with depression.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [207]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Liao, Q., Ming, J., Hu, G., Qing, C., & Li, Y. (2019) · Current Neurovascular Research · doi:10.2174/1567202616666190906102343 · Cited by 22
RetractedMicroglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
Neel, B. G., Gu, H., & Pao, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00091-4 · Cited by 1,249 · cited 2×
“Notably, SHP-2 and SHP-1 exert opposite biological functions [29] (Figure 2).”
BackgroundLassmann, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028936 · Cited by 937
Macrophage activation and its role in repair and pathology after spinal cord injury
Gensel, J. C., & Zhang, B. (2015) · Brain Research · doi:10.1016/j.brainres.2014.12.045 · Cited by 771
The CD47-SIRPα Immune Checkpoint
Logtenberg, M. E. W., Scheeren, F. A., & Schumacher, T. N. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.011 · Cited by 735 · cited 2×
“interactions with its ligands such as SIRPα, TSP-1, integrins, and SHPS-1, CD47 regulates numerous functions like cell adhesion, proliferation, apoptosis, migration, homeostasis, phagocytosis via macrophages–“don’t eat me signal”, neutrophils migration, and T-cells, B-cells and dendritic cells activation [1,2].”
BackgroundA family of proteins that inhibit signalling through tyrosine kinase receptors
Kharitonenkov, A., Chen, Z., Sures, I., Wang, H., Schilling, J., & Ullrich, A. (1997) · Nature · doi:10.1038/386181a0 · Cited by 662 · cited 10×
“phatases SH2 domain-containing phosphatase (SHP)-1 and SHP-2 [28].”
BackgroundInfluentialElaborate interactions between the immune and nervous systems
Steinman, L. (2004) · Nature Immunology · doi:10.1038/ni1078 · Cited by 556
CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development
Lehrman, E. K., Wilton, D. K., Litvina, E. Y., Welsh, C. A., Chang, S. T., Frouin, A., Walker, A. J., Heller, M. D., Umemori, H., Chen, C., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.017 · Cited by 468
Microglial Phagocytosis of Fibrillar β-Amyloid through a β1Integrin-Dependent Mechanism
Koenigsknecht, J., & Landreth, G. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2557-04.2004 · Cited by 446
Reynolds, A. D., Stone, D. K., Hutter, J. A. L., Benner, E. J., Mosley, R. L., & Gendelman, H. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901852 · Cited by 406
Regulatory T cells delay disease progression in Alzheimer-like pathology
Dansokho, C., Ait Ahmed, D., Aid, S., Toly-Ndour, C., Chaigneau, T., Calle, V., Cagnard, N., Holzenberger, M., Piaggio, E., Aucouturier, P., et al. (2016) · Brain · doi:10.1093/brain/awv408 · Cited by 359
The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications
Arranz, A. M., & De Strooper, B. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30490-3 · Cited by 334
Isenberg, J. S., Ridnour, L. A., Dimitry, J., Frazier, W. A., Wink, D. A., & Roberts, D. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605040200 · Cited by 289
Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses
Choi, C., & Benveniste, E. N. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.007 · Cited by 270 · cited 1×
“FasL is able to potentially stimulate apoptosis on FAS (FS-7-associated surface antigen) expressing activated T and NK cells [20] and as a result, limits the inflammatory processes in the brain [15].”
BackgroundCerebral Vascular Injury in Traumatic Brain Injury
Kenney, K., Amyot, F., Haber, M., Pronger, A., Bogoslovsky, T., Moore, C., & Diaz-Arrastia, R. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.019 · Cited by 267
Inflammation and ischaemic stroke
Muir, K. W., Tyrrell, P., Sattar, N., & Warburton, E. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32813ba151 · Cited by 264
Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.006 · Cited by 258
Neuroinflammation and neurodegeneration in overnutrition-induced diseases
Cai, D. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.11.003 · Cited by 256 · cited 1×
“Recently, interdisciplinary research in neurology and immunology has established a link between overeating and inflammation in the brain, and in particular, the hypothalamus [38].”
Backgroundvon Roemeling, C. A., Wang, Y., Qie, Y., Yuan, H., Zhao, H., Liu, X., Yang, Z., Yang, M., Deng, W., Bruno, K. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15129-8 · Cited by 242
Oldenborg, P.-A. (2013) · ISRN Hematology · doi:10.1155/2013/614619 · Cited by 235
Li, P., Marshall, L., Oh, G., Jakubowski, J. L., Groot, D., He, Y., Wang, T., Petronis, A., & Labrie, V. (2019) · Nature Communications · doi:10.1038/s41467-019-10101-7 · Cited by 234
Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?
Williams, A., Piaton, G., Aigrot, M.-S., Belhadi, A., Theaudin, M., Petermann, F., Thomas, J.-L., Zalc, B., & Lubetzki, C. (2007) · Brain · doi:10.1093/brain/awm202 · Cited by 227
Hatherley, D., Graham, S. C., Turner, J., Harlos, K., Stuart, D. I., & Barclay, A. N. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.026 · Cited by 215 · cited 5×
“Moreover, SIRP/CD47 signaling was instrumental to the cerebral infiltration of circulating monocytes.”
BackgroundInfluentialSignal Regulatory Proteins in the Immune System
van Beek, E. M., Cochrane, F., Barclay, A. N., & van den Berg, T. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7781 · Cited by 204
CD47: role in the immune system and application to cancer therapy
Hayat, S. M. G., Bianconi, V., Pirro, M., Jaafari, M. R., Hatamipour, M., & Sahebkar, A. (2020) · Cellular Oncology · doi:10.1007/s13402-019-00469-5 · Cited by 201
Self-citationKoning, N., Swaab, D. F., Hoek, R. M., & Huitinga, I. (2009) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181964113 · Cited by 187 · cited 1×
“These regulators include the proteins CX3CL1, CD47, and CD200, constitutively expressed by neurons, astrocytes, oligodendrocytes, and microglia, and involved in tissue resilience [11,12].”
BackgroundThe CD47-SIRP signalling system: its physiological roles and therapeutic application
Murata, Y., Kotani, T., Ohnishi, H., & Matozaki, T. (2014) · Journal of Biochemistry · doi:10.1093/jb/mvu017 · Cited by 169
Chitnis, T., Imitola, J., Wang, Y., Elyaman, W., Chawla, P., Sharuk, M., Raddassi, K., Bronson, R. T., & Khoury, S. J. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060677 · Cited by 164 · cited 1×
“These regulators include the proteins CX3CL1, CD47, and CD200, constitutively expressed by neurons, astrocytes, oligodendrocytes, and microglia, and involved in tissue resilience [11,12].”
BackgroundMicroglia Demonstrate Age-Dependent Interaction with Amyloid-β Fibrils
Floden, A. M., & Combs, C. K. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101014 · Cited by 162 · cited 1×
“These same authors also utilized acutely isolated microglia from mice of various ages and demonstrated a predominance of Aβ fibril phagocytosis in young microglia (harvested from day 0 pups) in a CD47-dependent manner; however, this effect was not observed in aged microglia obtained from 6-month-old mice [35].”
ResultWilcock, D. M., Lewis, M. R., Van Nostrand, W. E., Davis, J., Previti, M. L., Gharkholonarehe, N., Vitek, M. P., & Colton, C. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5066-07.2008 · Cited by 162
Mast Cells and Neuroinflammation
Dong, H., Zhang, X., & Qian, Y. (2014) · Medical Science Monitor Basic Research · doi:10.12659/msmbr.893093 · Cited by 160
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice
Han, M. H., Lundgren, D. H., Jaiswal, S., Chao, M., Graham, K. L., Garris, C. S., Axtell, R. C., Ho, P. P., Lock, C. B., Woodard, J. I., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20101974 · Cited by 157
Amyloid-β-Induced Astrocytic Phagocytosis is Mediated by CD36, CD47 and RAGE
Jones, R. S., Minogue, A. M., Connor, T. J., & Lynch, M. A. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9427-3 · Cited by 147 · cited 3×
“During neurological disorders, CD47 functions as a key neuroimmune modulator responding to chronic and acute CNS injuries and in the process of recovery [5,8].”
BackgroundGriffiths, M., Neal, J., & Gasque, P. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82002-2 · Cited by 146 · cited 2×
“Moreover, CD47, CD95L, CD55, CD200, fH, and CD46, all NIREGs, have been shown to contribute to downregulate immunity at the molecular and cellular levels and, thereby, suppress inflammation in the brain and other organs [13].”
BackgroundAlirezaei, Z., Pourhanifeh, M. H., Borran, S., Nejati, M., Mirzaei, H., & Hamblin, M. R. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01698-3 · Cited by 142
Gitik, M., Liraz-Zaltsman, S., Oldenborg, P.-A., Reichert, F., & Rotshenker, S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-24 · Cited by 141 · cited 1×
“of CD47 and SIRPα has been observed in microglia, whereas myelin, Schwann cells, oligodendrocytes, and astrocytes express CD47 without SIRPα [33].”
BackgroundYamao, T., Noguchi, T., Takeuchi, O., Nishiyama, U., Morita, H., Hagiwara, T., Akahori, H., Kato, T., Inagaki, K., Okazawa, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203287200 · Cited by 139 · cited 8×
“According to some studies, SHP-1 negatively regulates diverse signaling paths to inhibit numerous cell functions.”
BackgroundMethodInfluentialde Vries, H. E., Hendriks, J. J. A., Honing, H., de Lavalette, C. R., van der Pol, S. M. A., Hooijberg, E., Dijkstra, C. D., & van den Berg, T. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5832 · Cited by 134 · cited 1×
“Furthermore, interactions between CD47 on endothelial cells (ECs) and SIRP expressed on monocytes promoted the transmigration of monocytes in brain endothelium, which required G1-protein activation rather than monocyte adhesion [36].”
BackgroundAnti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro
Br�ck, W., & Friede, R. L. (1990) · Acta Neuropathologica · doi:10.1007/bf00307696 · Cited by 134
Teter, B., Morihara, T., Lim, G. P., Chu, T., Jones, M. R., Zuo, X., Paul, R. M., Frautschy, S. A., & Cole, G. M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.015 · Cited by 124
Narizhneva, N. V., Razorenova, O. V., Podrez, E. A., Chen, J., Chandrasekharan, U. M., DiCorleto, P. E., Plow, E. F., Topol, E. J., & Byzova, T. V. (2005) · The FASEB Journal · doi:10.1096/fj.04-3310fje · Cited by 124
Kosloski, L. M., Kosmacek, E. A., Olson, K. E., Mosley, R. L., & Gendelman, H. E. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.10.009 · Cited by 119
Neuroinflamm-Aging and Neurodegenerative Diseases: An Overview
Pizza, V., Agresta, A., W. D'Acunto, C., Festa, M., & Capasso, A. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711796235014 · Cited by 117 · cited 1×
“Moreover, neurodegenerative diseases may be followed by cognitive decline and seizures that are correlated to neuroinflammation [39].”
BackgroundLinnartz, B., & Neumann, H. (2013) · Glia · doi:10.1002/glia.22359 · Cited by 116 · cited 2×
“This regulation occurs through a cytoplasmic-domain, immuno-receptor tyrosine-based inhibition motif (ITIM), whereas receptor activation during microglia regulation occurs by a cytoplasmic-domain ITAM [27].”
BackgroundBryn, T., Mahic, M., Enserink, J., Schwede, F., Aandahl, E., & Taskén, K. (2006) · Journal of Immunology · doi:10.4049/jimmunol.176.12.7361 · Cited by 104
Jing, C., Bian, L., Wang, M., Keep, R. F., Xi, G., & Hua, Y. (2019) · Stroke · doi:10.1161/strokeaha.118.024578 · Cited by 103
Chung, E. S., Lee, G., Lee, C., Ye, M., Chung, H., Kim, H., Bae, S.-J. S., Hwang, D., & Bae, H. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500386 · Cited by 96
CD47 Promotes Neuronal Development through Src- and FRG/Vav2-Mediated Activation of Rac and Cdc42
Murata, T., Ohnishi, H., Okazawa, H., Murata, Y., Kusakari, S., Hayashi, Y., Miyashita, M., Itoh, H., Oldenborg, P., Furuya, N., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3981-06.2006 · Cited by 94 · cited 1×
“Another study showed the significant contribution of CD47-SIRPα interactions between neighboring neurons to the formation of the neuronal network in the hippocampus [32].”
BackgroundOlson, K. E., Kosloski, L. M., Anderson, K. M., Diggs, B. J., Clark, B. E., Gledhill, J. M., Shandler, S. J., Mosley, R. L., & Gendelman, H. E. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2131-15.2015 · Cited by 92
Law, A., O’Donnell, J., Gauthier, S. G., & Quirion, R. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00082-9 · Cited by 90
Gaikwad, S. M., Larionov, S., Wang, Y., Dannenberg, H., Matozaki, T., Monsonego, A., Thal, D. R., & Neumann, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090147 · Cited by 88 · cited 6×
“In addition, SIRPβ1 expression has been determined to occur on the cell surface as a disulfide-linked homodimer, which forms via Cys-320-mediated binding in the membrane-proximal Ig loop [26].”
BackgroundInfluentialDietary nutrition for neurological disease therapy: Current status and future directions
Mao, X., Yin, X., Guan, Q.-W., Xia, Q., Yang, N., Zhou, H., Liu, Z., & Jin, W. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107861 · Cited by 87 · cited 1×
“New research suggests that dietary nutrition helps prevent and cure neurological symptoms in a variety of conditions [37].”
BackgroundSaumet, A., Slimane, M. B., Lanotte, M., Lawler, J., & Dubernard, V. (2005) · Blood · doi:10.1182/blood-2004-09-3585 · Cited by 87
A Novel Role for Sema3A in Neuroprotection from Injury Mediated by Activated Microglia
Majed, H. H., Chandran, S., Niclou, S. P., Nicholas, R. S., Wilkins, A., Wing, M. G., Rhodes, K. E., Spillantini, M. G., & Compston, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0702-05.2006 · Cited by 86 · cited 1×
“Furthermore, oligodendrocytes express SEMA3A [16], which plays a role in inducing microglia apoptosis [17].”
BackgroundRegulation of the neurodegenerative process associated to Parkinson's disease by CD4+ T-cells
González, H., Contreras, F., & Pacheco, R. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9618-9 · Cited by 70
SIRP/CD47 signaling in neurological disorders
Zhang, H., Li, F., Yang, Y., Chen, J., & Hu, X. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.012 · Cited by 68 · cited 15×
“have been shown to be positively regulated by SHP-2 [5].”
BackgroundInfluentialThe enigma of cell death in neurodegenerative disorders
Jellinger, K. A., & Stadelmann, C. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_2 · Cited by 63 · cited 1×
“Additionally, neurodegeneration is accompanied by homeostatic changes in other CNS cells like astrocytes, microglia, and oligodendrocytes in varied forms that include cellular activation, glial scar formation, and cell death [40].”
BackgroundCD47 gene knockout protects against transient focal cerebral ischemia in mice
Jin, G., Tsuji, K., Xing, C., Yang, Y.-G., Wang, X., & Lo, E. H. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.02.004 · Cited by 62 · cited 3×
“Additionally, CD47 has broad involvement in the death of neuronal cells, inflammation, and the development of acute ischemic brain injuries [9,10].”
BackgroundIsenberg, J. S., Shiva, S., & Gladwin, M. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.05.005 · Cited by 60
Schwarzmaier, S. M., Zimmermann, R., McGarry, N., Trabold, R., Kim, S.-W., & Plesnila, N. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-32 · Cited by 60
Griffiths, M. R., Gasque, P., & Neal, J. W. (2010) · International Journal of Inflammation · doi:10.4061/2010/151097 · Cited by 58 · cited 16×
“Molecules 2021, 26, 3943 3 of 15 Interestingly, it has been shown that oligodendrocytes can express both CD47 and CD200 in order to control microglia behavior and inhibit specific immune reactions in the CNS [15].”
BackgroundInfluentialThe Role of Mast Cells in Alzheimer’s Disease
Shaik-Dasthagirisaheb, Y. B., & Conti, P. (2016) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/61914 · Cited by 57
Ohnishi, H., Kaneko, Y., Okazawa, H., Miyashita, M., Sato, R., Hayashi, A., Tada, K., Nagata, S., Takahashi, M., & Matozaki, T. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5173-04.2005 · Cited by 54 · cited 11×
“According to some studies, SHP-1 negatively regulates diverse signaling paths to inhibit numerous cell functions.”
BackgroundMethodInfluentialTreg Cells Protect Dopaminergic Neurons against MPP+ Neurotoxicity via CD47-SIRPA Interaction
Huang, Y., Liu, Z., Cao, B.-B., Qiu, Y.-H., & Peng, Y.-P. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000464388 · Cited by 54
Amyloid-β Inhibits No-cGMP Signaling in a CD36- and CD47-Dependent Manner
Miller, T. W., Isenberg, J. S., Shih, H. B., Wang, Y., & Roberts, D. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015686 · Cited by 52
Mahesula, S., Raphael, I., Raghunathan, R., Kalsaria, K., Kotagiri, V., Purkar, A. B., Anjanappa, M., Shah, D., Pericherla, V., Jadhav, Y. L. A., et al. (2012) · Electrophoresis · doi:10.1002/elps.201200515 · Cited by 50
Purinergic receptors in multiple sclerosis pathogenesis
Domercq, M., Zabala, A., & Matute, C. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.11.018 · Cited by 49
Amyloid β Peptides Trigger CD47-Dependent Mast Cell Secretory and Phagocytic Responses
Niederhoffer, N., Levy, R., Sick, E., Andre, P., Coupin, G., Lombard, Y., & Gies, J.-P. (2009) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200902200224 · Cited by 46
Spiers, J. G., Chen, H.-J. C., Bourgognon, J.-M., & Steinert, J. R. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.025 · Cited by 45
Ohnishi, H., Murata, T., Kusakari, S., Hayashi, Y., Takao, K., Maruyama, T., Ago, Y., Koda, K., Jin, F.-J., Okawa, K., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0257-10.2010 · Cited by 45
Wirtz-Brugger, F., & Giovanni, A. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00243-8 · Cited by 42
Gao, Q., Zhang, Y., Han, C., Hu, X., Zhang, H., Xu, X., Tian, J., Liu, Y., Ding, Y., Liu, J., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.03.002 · Cited by 40
CD47 knockout mice exhibit improved recovery from spinal cord injury
Myers, S. A., DeVries, W. H., Andres, K. R., Gruenthal, M. J., Benton, R. L., Hoying, J. B., Hagg, T., & Whittemore, S. R. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.12.010 · Cited by 38
Liu, S. Q., Alkema, P. K., Tieché, C., Tefft, B. J., Liu, D. Z., Li, Y. C., Sumpio, B. E., Caprini, J. A., & Paniagua, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503866200 · Cited by 35 · cited 1×
“In addition, SIRPβ1 expression has been determined to occur on the cell surface as a disulfide-linked homodimer, which forms via Cys-320-mediated binding in the membrane-proximal Ig loop [26].”
BackgroundRestoring immune suppression in the multiple sclerosis brain
Koning, N., Uitdehaag, B. M. J., Huitinga, I., & Hoek, R. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.09.005 · Cited by 32 · cited 1×
“Additionally, the expression of NIRegs via oligodendrocytes is highly important in the modulation of the immune response in the brain [18].”
BackgroundRole of oxidative stress and caspase 3 in CD47‐mediated neuronal cell death
Xing, C., Lee, S.-R., Kim, W. J., Jin, G., Yang, Y., Ji, X., Wang, X., & Lo, E. H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05777.x · Cited by 32 · cited 2×
“Additionally, CD47 has broad involvement in the death of neuronal cells, inflammation, and the development of acute ischemic brain injuries [9,10].”
BackgroundChanges of Fas and Fas ligand immunoreactivity after compression trauma to rat spinal cord
Li, G. L., Farooque, M., & Olsson, Y. (2000) · Acta Neuropathologica · doi:10.1007/s004010051195 · Cited by 32 · cited 1×
“Furthermore, another study determined that oligodendrocytes also express FasL which is a type-II transmembrane protein that belongs to the tumor necrosis factor (TNF) family [19].”
BackgroundActivation of CD47 receptors causes histamine secretion from mast cells
Sick, É., Niederhoffer, N., Takeda, K., Landry, Y., & Gies, J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8778-2 · Cited by 29
Bedoui, Y., Neal, J. W., & Gasque, P. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9793-6 · Cited by 28 · cited 1×
“Other NIREGS such as CD47, CD200, and CX3CL1 are important in tissue resilience in neurons or through the interaction with co-receptors (SIRPα, CD200R, and CX3CR1) in microglia, modulating the phenotypes from resting to an activated state, among other functions [14].”
BackgroundTang, X., Li, Z., Zhang, W., & Yao, Z. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.07.006 · Cited by 27
Microarray-based gene expression analysis of an animal model for closed head injury
Çolak, T., Çine, N., Bamaç, B., Kurtaş, Ö., Özbek, A., Biçer, Ü., Akkoyunlu, D. S., & Savlı, H. (2012) · Injury · doi:10.1016/j.injury.2012.01.021 · Cited by 26
CD47 deficiency improves neurological outcomes of traumatic brain injury in mice
Zhao, S., Yu, Z., Liu, Y., Bai, Y., Jiang, Y., van Leyen, K., Yang, Y., Lok, J. M., Whalen, M. J., Lo, E. H., et al. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.12.006 · Cited by 25
Martinelli, R., Newton, G. A., Carman, C., Greenwood, J., & Luscinskas, F. (2013) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301903 · Cited by 25
β‐Amyloid Vasoactivity and Proinflammation in Microglia Can Be Blocked by cGMP‐Elevating Agents
Paris, D., Town, T., Parker, T. A., Humphrey, J., & MULLAN, M. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06397.x · Cited by 22
Leclair, P., & Lim, C. J. (2020) · Animal Cells and Systems · doi:10.1080/19768354.2020.1818618 · Cited by 22 · cited 2×
“interactions with its ligands such as SIRPα, TSP-1, integrins, and SHPS-1, CD47 regulates numerous functions like cell adhesion, proliferation, apoptosis, migration, homeostasis, phagocytosis via macrophages–“don’t eat me signal”, neutrophils migration, and T-cells, B-cells and dendritic cells activation [1,2].”
BackgroundCD47 does not mediate amyloid-β(1–42) protofibril-stimulated microglial cytokine release
Karki, S., & Nichols, M. R. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.081 · Cited by 11
Brain Ischemia and Reperfusion
Belayev, L., Lu, Y., & Bazan, N. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00035-3 · Cited by 11
Sanson, C. (2017) · theses.fr (ABES) · doi:10.70675/205f3741zaac1z422eza6aeza2902010260f · Cited by 1
Cited by
Tartt, A. N., Mariani, M. B., Hen, R., Mann, J. J., & Boldrini, M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01520-y · Cited by 408
“, CD47 which is implicated in neuroinflammatory cascades [207]), and proinflammatory markers (IL-1β, IL-6) [208–211] that are associated with depression.”
BackgroundPhagocytic microglia and macrophages in brain injury and repair
Yu, F., Wang, Y., Stetler, A. R., Leak, R. K., Hu, X., & Chen, J. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13899 · Cited by 203
Internal m7G methylation: A novel epitranscriptomic contributor in brain development and diseases
Xia, X., Wang, Y., & Zheng, J. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.01.003 · Cited by 95
Hayes, A. J., & Melrose, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021148 · Cited by 34
“CD47 protects synapses from excess microglia-mediated remodelling during tissue development and trauma [379] and has neuroprotective roles in neuroinflammatory processes occurring during pathological tissue remodelling in neurodegenerative disorders that reduce cognitive processes and memory [380,381].”
BackgroundGlymphatic system clearance and Alzheimer’s disease risk: a CSF proteome-wide study
Cullell, N., Caruana, G., Elias-Mas, A., Delgado-Sánchez, A., Artero, C., Buongiorno, M., Almería, M., Ray, N. J., Corrêa, S. A. L., & Krupiński, J. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01612-7 · Cited by 33
Metadata
- Authors
- Gheibihayat, S. M., Cabezas, R., Nikiforov, N. G., Jamialahmadi, T., Johnston, T. P., & Sahebkar, A.
- Affiliations
- Department of Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd 8916188635, Iran
- Universidad Antonio Nariño (CO)
- Institute of Experimental Cardiology (RU)
- Mashhad University of Medical Sciences (IR)
- University of Missouri–Kansas City (US)
- Corresponding author
- Sahebkar, Amirhossein
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2021-06-28
- Volume
- 26
- Issue
- 13
- Pages
- 3943
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC8271744
- OpenAlex
- W3174672518
- Cited by
- 34
- References
- 91
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 8 · 2023: 6 · 2022: 4
- FWCI
- 0.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Russian Science Foundation (20-15-00337)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- CD47, SIRPα, neurodegeneration, neuroinflammation, central nervous system, phagocytosis, macrophages, thrombospondin-1, integrins, therapeutic targeting, multiple sclerosis, stroke
- MeSH terms
- Animals, Brain, Gaucher Disease, Humans, Inflammation, Multiple Sclerosis, Stroke, CD47 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.